Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 73

1.

Epidermal growth factor-dependent enhancement of invasiveness of squamous cell carcinoma of the breast.

Kimura F, Iwaya K, Kawaguchi T, Kaise H, Yamada K, Mukai K, Matsubara O, Ikeda N, Kohno N.

Cancer Sci. 2010 May;101(5):1133-40. doi: 10.1111/j.1349-7006.2010.01527.x. Epub 2010 Feb 8.

2.

Epidermal growth factor-like ligands differentially up-regulate matrix metalloproteinase 9 in head and neck squamous carcinoma cells.

O-charoenrat P, Modjtahedi H, Rhys-Evans P, Court WJ, Box GM, Eccles SA.

Cancer Res. 2000 Feb 15;60(4):1121-8.

3.

Epidermal growth factor stimulation can substitute for c-Src overexpression in promoting breast carcinoma invasion.

Lotz M, Wang HH, Cance W, Matthews J, Pories S.

J Surg Res. 2003 Feb;109(2):123-9.

PMID:
12643853
5.

Activation of H-Ras and Rac1 correlates with epidermal growth factor-induced invasion in Hs578T and MDA-MB-231 breast carcinoma cells.

Koh MS, Moon A.

Biochem Biophys Res Commun. 2011 Mar 4;406(1):25-9. doi: 10.1016/j.bbrc.2011.01.092. Epub 2011 Jan 31.

PMID:
21281602
6.

Overexpression of cortactin increases invasion potential in oral squamous cell carcinoma.

Yamada S, Yanamoto S, Kawasaki G, Mizuno A, Nemoto TK.

Pathol Oncol Res. 2010 Dec;16(4):523-31. doi: 10.1007/s12253-009-9245-y. Epub 2010 Jan 13.

PMID:
20069395
7.
8.

Epidermal growth factor receptor-stimulated activation of phospholipase Cgamma-1 promotes invasion of head and neck squamous cell carcinoma.

Thomas SM, Coppelli FM, Wells A, Gooding WE, Song J, Kassis J, Drenning SD, Grandis JR.

Cancer Res. 2003 Sep 1;63(17):5629-35.

9.

A role for phospholipase C-gamma-mediated signaling in tumor cell invasion.

Kassis J, Moellinger J, Lo H, Greenberg NM, Kim HG, Wells A.

Clin Cancer Res. 1999 Aug;5(8):2251-60.

10.
11.

Uncoupling of epidermal growth factor-dependent proliferation and invasion in a model of squamous carcinoma progression.

Yeudall WA, Miyazaki H, Ensley JF, Cardinali M, Gutkind JS, Patel V.

Oral Oncol. 2005 Aug;41(7):698-708.

PMID:
15935723
12.
13.

A Cortactin-CD2-associated protein (CD2AP) complex provides a novel link between epidermal growth factor receptor endocytosis and the actin cytoskeleton.

Lynch DK, Winata SC, Lyons RJ, Hughes WE, Lehrbach GM, Wasinger V, Corthals G, Cordwell S, Daly RJ.

J Biol Chem. 2003 Jun 13;278(24):21805-13. Epub 2003 Apr 2.

14.
15.

Epidermal growth factor receptor-dependent cytotoxic effect by an EGF-ribonuclease conjugate on human cancer cell lines--a trial for less immunogenic chimeric toxin.

Jinno H, Ueda M, Ozawa S, Kikuchi K, Ikeda T, Enomoto K, Kitajima M.

Cancer Chemother Pharmacol. 1996;38(4):303-8.

PMID:
8674151
16.

A neural Wiskott-Aldrich Syndrome protein-mediated pathway for localized activation of actin polymerization that is regulated by cortactin.

Kempiak SJ, Yamaguchi H, Sarmiento C, Sidani M, Ghosh M, Eddy RJ, Desmarais V, Way M, Condeelis J, Segall JE.

J Biol Chem. 2005 Feb 18;280(7):5836-42. Epub 2004 Dec 4.

17.

Large isoform of MRJ (DNAJB6) reduces malignant activity of breast cancer.

Mitra A, Fillmore RA, Metge BJ, Rajesh M, Xi Y, King J, Ju J, Pannell L, Shevde LA, Samant RS.

Breast Cancer Res. 2008;10(2):R22. doi: 10.1186/bcr1874. Epub 2008 Mar 7.

18.
19.

Overexpression of cortactin in head and neck squamous cell carcinomas can be uncoupled from augmented EGF receptor expression.

Fantozzi I, Grall D, Cagnol S, Stanchi F, Sudaka A, Brunstein MC, Bozec A, Fischel JL, Milano G, Van Obberghen-Schilling E.

Acta Oncol. 2008;47(8):1502-12. doi: 10.1080/02841860802089801.

PMID:
18607838
20.

Radiosensitization of Ras-mutated human tumor cells in vitro by the specific EGF receptor antagonist BIBX1382BS.

Toulany M, Dittmann K, Baumann M, Rodemann HP.

Radiother Oncol. 2005 Feb;74(2):117-29. Epub 2004 Dec 9.

PMID:
15734199

Supplemental Content

Support Center